Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Early growth in manufacturing.In 1946, United Research Laboratories (URL) was founded by Albert Roberts, a bench chemist with a degree from the University of Pittsburgh.
In 1984, seeing that their manufacturers were starting to bypass distributors like URL, Mr.
In 1988, Albert Roberts’ son, Richard H. Roberts, M.D., Ph.D., left the Brigham and Women’s Hospital, of Harvard Medical School, to join the Company.
Doctor Richard Roberts became the Chief Operating Officer in 1989, assuming control of the operations and leading the company to profitability.
In 1997, venture capital investors (Elliott Associates and Momar Corporation) purchased a majority of the company.
From generic excellence to branding expertise.By 2001, URL Pharma had achieved significant growth with net sales exceeding $100 million.
In 2006, URL launched Qualaquin® (quinine sulfate), the Company’s first internally developed branded product and the only FDA-approved version of quinine sulfate.
By 2007, the Company had annual sales of $483 million, more than 250 approved ANDAs, 4 approved NDAs, licensing deals, multiple high-barrier ANDAs, and a broad portfolio of proprietary products under development.
In 2008, the Company changed its name to URL Pharma, Inc.
In 2009, URL Pharma received FDA approval of its NDAs for COLCRYS® and FIBRICOR® and commercially launched these products in the third quarter of the year, continuing the Company’s evolution into a specialty pharmaceutical provider.
On June 4, 2012, Takeda Pharmaceuticals United StatesA., Inc., completed its acquisition of URL Pharma, Inc.
Qualaquin® has Orphan Drug Exclusivity for the treatment of malaria until August 2012.
Rate how well URL Pharma lives up to its initial vision.
Do you work at URL Pharma?
Is URL Pharma's vision a big part of strategic planning?
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Roxane Laboratories | 1885 | $4.2M | 42 | 4 |
| Teva Pharmaceuticals | 1901 | $16.5B | 4,999 | 184 |
| XenoPort, Inc. | - | $41.2M | 200 | - |
| Tergus Pharma | 1994 | $11.6M | 116 | 6 |
| Par Pharmaceutical Inc | 2003 | $260.0M | 400 | - |
| Tris Pharma | 2000 | $102.0M | 200 | 8 |
| Pharmaceutics International | 1994 | $367.8M | 1,000 | 8 |
| Watson Pharma Pvt Ltd | 1984 | $5.9B | 21,600 | - |
| Watson Laboratories | 1992 | $37.0M | 50 | - |
| Contract Pharmacal | 1971 | $54.0M | 79 | 16 |
Zippia gives an in-depth look into the details of URL Pharma, including salaries, political affiliations, employee data, and more, in order to inform job seekers about URL Pharma. The employee data is based on information from people who have self-reported their past or current employments at URL Pharma. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by URL Pharma. The data presented on this page does not represent the view of URL Pharma and its employees or that of Zippia.
URL Pharma may also be known as or be related to Mutual Pharmaceutical Company, Inc., URL Pharma, URL Pharma, Inc. and Url Pharma, Inc.